Zammit Andrea R, de Pavia Lopes Katia, Batalha Caio M P F, Yu Lei, Poole Victoria N, Tasaki Shinya, Kapasi Alifiya, Wang Yanling, De Jager Philip L, Menon Vilas, Seyfried Nicholas T, Kaddurah-Daouk Rima, Iturria-Medina Yasser, Bennett David A
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.
bioRxiv. 2025 May 21:2025.05.19.654904. doi: 10.1101/2025.05.19.654904.
Molecular mechanisms linking neuroticism with Alzheimer's disease traits are unknown.
To identify molecular subtypes of neuroticism and examine their association with ADRD traits.
Three ongoing cohort studies were used; Religious Orders Study (ROS), Rush Memory and Aging Project (MAP) and Minority Aging Research Study (MARS), that began enrollment in 1994, 1997, and 2004, respectively.
Older priests, nuns, and brothers from across the U.S. (ROS), older adults (MAP) and older African-American adults (MARS) from across the greater Chicago metropolitan area.
1,028 decedents with multi-omic data from the dorsolateral prefrontal cortex (DLPFC), the anterior cingulate cortex (AC), and the posterior cingulate gyrus (PCG).
Eight layers of omics (DNA methylation and histone acetylation from DLPFC; RNA seq from AC, DLPFC, and PCG, single-nucleus RNA, TMT proteomics and metabolomics from DLPFC) and Neuroticism using the 12-item version from the NEO Five-Factor Inventory.
Person-specific multi-omic molecular pseudotime representing molecular progression from low to high phenotypic expression of neuroticism, and three multi-omic brain molecular subtypes of neuroticism which represent distinct omic pathways from no/low neuroticism to high neuroticism that differ by their omic constituents. Participants are exclusively assigned to the subtype which aligns mostly with their multi-omic profile.
The top drivers of subtype differentiation were transcriptomic alterations across three brain regions (DLPFC, AC, PCG) which extensively and differentially characterized the subtypes. The subtypes were also differentially associated with AD pathology, temporal lobe atrophy, and AD dementia, with subtype N showing the strongest associations.
Neuroticism may be driven by three distinct molecular subtypes, with subtype N driving ADRD-related associations, N showing some ADRD associations, and N being completely independent of these outcomes. Our data provide novel insights into the biology of individual differences in predispositions of neuroticism and its associations with ADRD traits.
将神经质与阿尔茨海默病特征联系起来的分子机制尚不清楚。
确定神经质的分子亚型,并研究它们与阿尔茨海默病相关痴呆(ADRD)特征的关联。
使用了三项正在进行的队列研究;宗教团体研究(ROS)、拉什记忆与衰老项目(MAP)和少数族裔衰老研究(MARS),分别于1994年、1997年和2004年开始招募。
来自美国各地的老年牧师、修女和修士(ROS)、来自大芝加哥都会区的老年人(MAP)和老年非裔美国成年人(MARS)。
1028名死者,他们拥有来自背外侧前额叶皮层(DLPFC)、前扣带回皮层(AC)和后扣带回(PCG)的多组学数据。
八层组学(来自DLPFC的DNA甲基化和组蛋白乙酰化;来自AC、DLPFC和PCG的RNA测序、单核RNA、来自DLPFC的TMT蛋白质组学和代谢组学)以及使用NEO五因素问卷12项版本测量的神经质。
代表从低到高神经质表型表达的分子进展的个体特异性多组学分子伪时间,以及三种神经质的多组学脑部分子亚型,它们代表从无/低神经质到高神经质的不同组学途径,其组学成分不同。参与者仅被分配到与其多组学概况最相符的亚型。
亚型分化的主要驱动因素是三个脑区(DLPFC、AC、PCG)的转录组改变,这些改变广泛且不同地刻画了各亚型。这些亚型与AD病理、颞叶萎缩和AD痴呆也存在差异关联,其中亚型N显示出最强的关联。
神经质可能由三种不同的分子亚型驱动,其中亚型N驱动与ADRD相关的关联,亚型N显示出一些与ADRD的关联,而亚型N与这些结局完全无关。我们的数据为神经质易感性个体差异的生物学机制及其与ADRD特征的关联提供了新的见解。